Akers Biosciences Inc
AKER - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$643.89K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $643,887.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-57.39 |
| Beta | - |
| Outstanding Shares | 260,683 |
Return
| Return on Equity | -57.14% |
|---|---|
| Return on Assets | -100.40% |
| Return on Invested Capital | -108.86% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 2.47 |
| Price to Book Ratio | 0.04 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Akers Biosciences Inc
CEO: Howard Yeaton
